Company attributes
Other attributes
Nevro is a medical device company with the simple goal of helping more patients who are suffering from chronic pain to achieve lasting relief. Nevro pursues clinical research to better support healthcare providers in treating chronic pain.
The company creates HFX, a comprehensive solution for individualized relief of chronic pain to help physicians to meet the diverse needs of patients by providing: Innovative Technologies, Advanced Therapies, Services & Support and Meaningful Evidence.
Nevro created a disruption by offering a next-generation approach called 10 kHz Therapy, the most studied therapy in the market, that provides patients with significant pain relief and no paresthesia.
The company's product, Nevro® Senza® SCS System for 10 kHz Therapy, received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
